Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Wagner

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
British Journal of Haematology|June 8, 2017
Centre characteristics and procedure-related factors have an impact on outcomes of allogeneic transplantation for patients with CLL: a retrospective analysis from the European Society for Blood and Marrow Transplantation (EBMT)Johannes Schetelig, Liesbeth C de Wreede, Niels S Andersen, et al.
Journal of Hematology & Oncology|February 21, 2026
Allogeneic stem cell transplantation for major T-cell lymphoma entities: an analysis of the EBMT-lymphoma working partyEvgenii Shumilov, Maud Ngoya, Philipp Berning, et al.
Circulation Research|July 16, 2024
Dysferlin Enables Tubular Membrane Proliferation in Cardiac HypertrophyNora Josefine Paulke, Carolin Fleischhacker, Justus B Wegener, et al.
Haematologica|December 28, 2019
Standardized monitoring of cytomegalovirus-specific immunity can improve risk stratification of recurrent cytomegalovirus reactivation after hematopoietic stem cell transplantationEva Wagner-Drouet, Daniel Teschner, Christine Wolschke, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 12, 2017
Baseline Characteristics Predicting Very Good Outcome of Allogeneic Hematopoietic Cell Transplantation in Young Patients With High Cytogenetic Risk Chronic Lymphocytic Leukemia - A Retrospective Analysis From the Chronic Malignancies Working Party of the EBMTMichel van Gelder, Dimitris Ziagkos, Liesbeth de Wreede, et al.
Leukemia|May 8, 2023
Allogeneic hematopoietic stem cell transplantation for NK/T-cell lymphoma: an international collaborative analysisPhilipp Berning, Norbert Schmitz, Maud Ngoya, et al.
The EMBO Journal|November 18, 2017
Glyoxal as an alternative fixative to formaldehyde in immunostaining and super-resolution microscopyKatharina N Richter, Natalia H Revelo, Katharina J Seitz, et al.
Nature Medicine|October 23, 2023
CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trialAndreas Mackensen, John B A G Haanen, Christian Koenecke, et al.
Frontiers in Immunology|November 15, 2023
Prevention of CMV/EBV reactivation by double-specific T cells in patients after allogeneic stem cell transplantation: results from the randomized phase I/IIa MULTIVIR-01 studyArmin Gerbitz, Regina Gary, Michael Aigner, et al.
Blood|January 29, 2021
A randomized phase 3 trial of autologous vs allogeneic transplantation as part of first-line therapy in poor-risk peripheral T-NHLNorbert Schmitz, Lorenz Truemper, Krimo Bouabdallah, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
British Journal of Haematology|June 8, 2017
Centre characteristics and procedure-related factors have an impact on outcomes of allogeneic transplantation for patients with CLL: a retrospective analysis from the European Society for Blood and Marrow Transplantation (EBMT)Johannes Schetelig, Liesbeth C de Wreede, Niels S Andersen, et al.
Journal of Hematology & Oncology|February 21, 2026
Allogeneic stem cell transplantation for major T-cell lymphoma entities: an analysis of the EBMT-lymphoma working partyEvgenii Shumilov, Maud Ngoya, Philipp Berning, et al.
Circulation Research|July 16, 2024
Dysferlin Enables Tubular Membrane Proliferation in Cardiac HypertrophyNora Josefine Paulke, Carolin Fleischhacker, Justus B Wegener, et al.
Haematologica|December 28, 2019
Standardized monitoring of cytomegalovirus-specific immunity can improve risk stratification of recurrent cytomegalovirus reactivation after hematopoietic stem cell transplantationEva Wagner-Drouet, Daniel Teschner, Christine Wolschke, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 12, 2017
Baseline Characteristics Predicting Very Good Outcome of Allogeneic Hematopoietic Cell Transplantation in Young Patients With High Cytogenetic Risk Chronic Lymphocytic Leukemia - A Retrospective Analysis From the Chronic Malignancies Working Party of the EBMTMichel van Gelder, Dimitris Ziagkos, Liesbeth de Wreede, et al.
Leukemia|May 8, 2023
Allogeneic hematopoietic stem cell transplantation for NK/T-cell lymphoma: an international collaborative analysisPhilipp Berning, Norbert Schmitz, Maud Ngoya, et al.
The EMBO Journal|November 18, 2017
Glyoxal as an alternative fixative to formaldehyde in immunostaining and super-resolution microscopyKatharina N Richter, Natalia H Revelo, Katharina J Seitz, et al.
Nature Medicine|October 23, 2023
CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trialAndreas Mackensen, John B A G Haanen, Christian Koenecke, et al.
Frontiers in Immunology|November 15, 2023
Prevention of CMV/EBV reactivation by double-specific T cells in patients after allogeneic stem cell transplantation: results from the randomized phase I/IIa MULTIVIR-01 studyArmin Gerbitz, Regina Gary, Michael Aigner, et al.
Blood|January 29, 2021
A randomized phase 3 trial of autologous vs allogeneic transplantation as part of first-line therapy in poor-risk peripheral T-NHLNorbert Schmitz, Lorenz Truemper, Krimo Bouabdallah, et al.
Pageof 8